MLGPF Meldex International Plc featured news, full reports, and detailed charts
Meldex International Plc (MLGPF/MLGPF.PK) Wrap Up:
Meldex International Plc operates as a pharmaceutical and healthcare product company that uses XGEL polymer technologies to develop and enhance medicines and over-the-counter products. Its primary products include RocGel, an antacid indicated for the treatment of oesopho gastroduodenal conditions; Collunovar that is a chlorhexidine mouth-spray for the treatment of gingivitis and sore throats; Artisial/Hypozalix, which is an artificial saliva incorporating a naturally-based polymer in a mouth-spray; Menoflavon that is for women who suffer from mild to medium disorders in general wellbeing; Slimthru, a weight and food management product; and Ah-Chew, a chewable tablet that offer relief of alle...Meldex International Plc (MLGPF:OTC)
|
Market Cap
2.1M
|
Total Revenue
42.1M
|
|
|
EBITDA
3.6M
|
DILUTED EPS TTM
0.01
|
|
|
P/E
0.4x
|
P/S
0.0x
|
|
|
Return On Asset
--
|
Return On Equity
--
|
|
| K = Thousands M = Millions B = Billions | ||
related news
A day trader whose activities have drawn regulators' scrutiny could end up taking home the big check
MLGPF Top Compensated Officers
Executives, Board Directors
Key developments for Meldex International Plc (MLGPF)
Meldex International Plc has entered into a distribution agreement with Jamieson Laboratories Ltd., under which Jamieson would sell and distribute its Menoflavon(R) range of products in Canada.
Meldex International Plc has signed a sales and distribution agreement with Delta Medical Establishment for Meldex's Menoflavon(R) range of products and Melprotect(R) in the United Arab Emirates. Delta Medical is an Abu Dhabi-based suppliers of medical, health, and beauty care products and equipments. Menoflavon is a natural supplement for women who suffer from disorders in general well-being during the menopause and Melprotect Propolis is a natural substance and has a soothing effect on skin and mucous membranes.
Meldex International Plc has signed an agreement with NeoCare S.A., for the distribution of the Menoflavon(R) range of products. Under the alliance, NeoCare will distribute Menoflavon(R) range of products in Belgium and Luxembourg.
MLGPF Competitors
| Company | Last | Change |
| Auriga Laboratories Inc | $0.0010 USD | 0.00 |
| GlaxoSmithKline | 1,254 GBX | +13.00 |
| UCB | €30.60 EUR | -0.205 |
| Market data is delayed at least 20 minutes. | ||
Industry Analysis
| Valuation | MLGPF | Industry Range |
| Price/Earnings | 0.4x |
|
| Price/Sales | 0.0x |
|
| Price/Book | 0.0x |
|
| Price/Cash Flow | 0.3x |
|
| TEV/Sales | NM | Not Meaningful |
|
MLGPF |
||
MLGPF transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||